Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,470 | -10,330 | -5,880 | -24,720 | -36,750 |
| Depreciation Amortization | 5,760 | 4,400 | 2,260 | 27,850 | 15,930 |
| Other Working Capital | -4,620 | -4,220 | -4,660 | -16,490 | 12,790 |
| Other Operating Activity | -3,410 | -6,690 | -2,530 | -10,770 | -5,950 |
| Operating Cash Flow | $-22,740 | $-16,840 | $-10,810 | $-24,130 | $-13,980 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 1 | -20 | -10 | -500 | -460 |
| Other Investing Activity | 0 | 0 | 0 | -590 | -1,140 |
| Investing Cash Flow | $1 | $-20 | $-10 | $-1,090 | $-1,600 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 25,090 | 25,110 | -20 | 14,200 | 9,110 |
| Financing Cash Flow | $25,090 | $25,110 | $-20 | $14,200 | $9,110 |
| Exchange Rate Effect | -580 | -1,030 | -290 | -90 | 300 |
| Beginning Cash Position | 38,100 | 38,100 | 38,100 | 49,220 | 49,220 |
| End Cash Position | 39,860 | 45,310 | 26,940 | 38,100 | 43,050 |
| Net Cash Flow | $1,760 | $7,210 | $-11,150 | $-11,120 | $-6,170 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,740 | -16,840 | -10,810 | -24,130 | -13,980 |
| Free Cash Flow | -22,740 | -16,840 | -10,810 | -24,130 | -13,980 |